Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M--Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M--ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with VHT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VHTKen Fisher 2015-12-31 Buy $123.27 - $134.76
($130.49)
$ 116.64-11%New holding1,808
VHTKen Fisher 2013-12-31 Buy $91.43 - $97.64
($95.51)
$ 116.6422%New holding3,028
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VHT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VHT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sartor, RobertSenior Officer 2016-02-05Buy1,400$5.352080.19view
Arrow Capital Management Inc.Director or Senior Officer of Insider or Subsidiar 2016-02-05Buy1,000$5.52020.73view
Martin, Paul DouglasDirector, Senior Officer 2016-02-05Sell19,600$18.95515.51view
Martin, Paul DouglasDirector, Senior Officer 2016-02-05Sell19,700$18.96515.19view
Martin, Paul DouglasDirector, Senior Officer 2016-02-05Sell5,600$18.97514.87view
Martin, Paul DouglasDirector, Senior Officer 2016-02-05Sell12,700$19513.89view
Martin, Paul DouglasDirector, Senior Officer 2016-02-05Sell2,900$18.99514.22view
Martin, Paul DouglasDirector, Senior Officer 2016-02-05Sell2,100$19.05512.28view
Martin, Paul DouglasDirector, Senior Officer 2016-02-05Sell1,600$19.03512.93view
Martin, Paul DouglasDirector, Senior Officer 2016-02-05Sell1,900$19.02513.25view

Quarterly/Annual Reports about VHT:

    News about VHT:

    Articles On GuruFocus.com
    Mario Gabelli Adds More Shares in Comcast Feb 07 2016 
    Weekly CFO Buys Highlight: Radian Group, Zions Bancorp, Talmer Bancorp Feb 07 2016 
    Seth Klarman Finds Hidden Value in Pharmaceutical Company Feb 07 2016 
    Lululemon: What Is Steve Mandel's Thesis? Feb 07 2016 
    Donald Yacktman Increases America's Car-Mart Holding Feb 07 2016 
    Lou Simpson Adds to Valeant Stake Feb 07 2016 
    Mr. Market and a Valuation of the Dow Jones Industrial Average - February Feb 07 2016 
    Spirit Airlines' Low Cost Advantage Positioned for Long-Term Profitability Feb 07 2016 
    Incompetent Management May Kill GoPro Feb 07 2016 
    Yacktman Fund Comments on Staples Feb 05 2016 

    More From Other Websites
    Abbott Stock Has Bear Run after 4Q15 Earnings Release Feb 04 2016
    Anthem’s Medical Care Ratio Jumped in 4Q15 Feb 02 2016
    Can Boston Scientific Maintain Its Growth Momentum? Feb 01 2016
    Humana Acquisition Could Be Aetna’s Key Long-Term Growth Driver Jan 29 2016
    J&J Earnings Beat Fails to Cheer Healthcare ETFs Jan 28 2016
    Optum Reported Strong Revenue and Earnings Growth in 2015 Jan 27 2016
    Thermo Fisher: Analytics Instruments and Specialty Diagnostics Jan 10 2016
    Looking at Future Estimates by Analysts for Pfizer Jan 07 2016
    The Pfizer–Allergan Deal: 4Q15 Brings the Biggest Pharma Merger Jan 07 2016
    The Top 5 Health Care ETFs for 2016 (XLV, VHT) Jan 07 2016
    Markets Recharge with a Nap…Zzz Jan 07 2016
    Pfizer’s 4Q15 Earnings: Products Offsetting Growth Jan 05 2016
    Pfizer’s Revenues for 4Q15 Are Expected to Grow Jan 04 2016
    Health Care Stocks: Growth Prescriptions for 2016 Jan 01 2016
    VHT: Vanguard Health Care EFT Dec 25 2015
    Here's Why Medtronic Remains Attractive Despite Its Pricey Valuation Dec 02 2015
    Calls for the demise of Obamacare 'may be premature' Nov 29 2015
    Keytruda: Hope for Merck’s Immuno-Oncology Franchise Nov 26 2015
    Remicade: A Falling Drug in Merck’s Immunology Franchise Nov 26 2015
    Gardasil Is Driving Merck’s Vaccine Business Nov 12 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    Purcelm2
    ReplyPurcelm2 - 1 year ago
    1
    Gurufocus
    ReplyGurufocus - 2 years ago
    test
    Don Li
    ReplyDon Li - 2 years ago
    test 38
    Gurufocus
    ReplyGurufocus - 2 years ago
    test37
    Gurufocus
    ReplyGurufocus - 2 years ago
    test 36
    Don Li
    ReplyDon Li - 2 years ago
    test 24
    Don Li
    ReplyDon Li - 2 years ago
    test 23
    Rommy
    ReplyRommy - 2 years ago
    How do I create portfolio using GureFocus?
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK